Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…